Chronic Phase Marker Market, Global Outlook and Forecast 2023-2030
Markers are broadly categorized as biomarkers or molecular markers and biochemical markers. Biomarker, also known as biological marker is commonly used to carry out detection of living organism which acts as a causative agent for specific diseases. It usually refers to a measurable indicator for various biological states or disease conditions in the human body. Biomarker is any substance that can be utilized as an indicator of specific disease condition and is often evaluated to detect pathogenic processes, normal biological process, or pharmacologic response to medical treatment. The elevated levels or absence of these biological markers may indicate the onset or late stage of a chronic disease. However, chronic phase indicates early stages of chronic leukemia which is a type of cancer in white blood cells. It constitutes high amounts of abnormal white blood cells in bone marrow and blood. Chronic phase markers are the biomarkers that help in detection of a disease condition with the presence of their elevated levels in patient?s body.
This report aims to provide a comprehensive presentation of the global market for Chronic Phase Marker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Phase Marker. This report contains market size and forecasts of Chronic Phase Marker in global, including the following market information:
Global Chronic Phase Marker Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Chronic Phase Marker market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Tumor Markers Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Chronic Phase Marker include Nordic BioSite, DiaSorin, Roche, Bristol-Myers Squibb, Hologic, QIAGEN, Philips, Johnson & Johnson and Lifesign, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Chronic Phase Marker companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chronic Phase Marker Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Chronic Phase Marker Market Segment Percentages, by Type, 2022 (%)
Tumor Markers
Cardiac Markers
Thyroid Markers
Others
Global Chronic Phase Marker Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Chronic Phase Marker Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Diagnostic Laboratories
Global Chronic Phase Marker Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Chronic Phase Marker Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chronic Phase Marker revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Chronic Phase Marker revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Nordic BioSite
DiaSorin
Roche
Bristol-Myers Squibb
Hologic
QIAGEN
Philips
Johnson & Johnson
Lifesign
Natus
BrainScope
Outline of Major Chapters:
Chapter 1: Introduces the definition of Chronic Phase Marker, market overview.
Chapter 2: Global Chronic Phase Marker market size in revenue.
Chapter 3: Detailed analysis of Chronic Phase Marker company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chronic Phase Marker in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
